Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1499-1505
Published online before print April 21, 2005, doi: 10.1161/01.ATV.0000167526.31611.f6
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/7/1499    most recent
01.ATV.0000167526.31611.f6v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keuren, J. F.W.
Right arrow Articles by Lindhout, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keuren, J. F.W.
Right arrow Articles by Lindhout, T.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1499.)
© 2005 American Heart Association, Inc.


Thrombosis

Synergistic Effect of Thrombin on Collagen-Induced Platelet Procoagulant Activity Is Mediated Through Protease-Activated Receptor-1

Jeffrey F.W. Keuren; Simone J.H. Wielders; Hans Ulrichts; Tilman Hackeng; Johan W.M. Heemskerk; Hans Deckmyn; Edouard M. Bevers; Theo Lindhout

From the Sanquin (J.F.W.K.), Blood Bank region South-East, Maastricht, and the Department of Biochemistry (S.J.H.W., T.H., J.W.M.H., E.M.B., T.L.), Cardiovascular Research Institute Maastricht, Maastricht University, the Netherlands; and the Laboratory for Thrombosis Research (H.U., H.D.), K.U. Leuven, Campus Kortrijk, Belgium.

Correspondence to Dr T. Lindhout, Department of Biochemistry, Maastricht University, PO Box 616, 6200 MD Maastricht, the Netherlands. E-mail t.lindhout{at}bioch.unimaas.nl

Objective— In the blood coagulation process, the rate of thrombin formation is critically dependent on phosphatidylserine (PtdSer) at the surface of activated platelets. Thrombin synergistically enhances the collagen-induced platelet procoagulant response. The objective of this study is to elucidate the mechanism of this synergistic action with a focus on the intracellular Ca2+ concentration ([Ca2+]i) and the various platelet receptors for thrombin.

Methods and Results— We demonstrate that procoagulant activity is related to a sustained increased [Ca2+]i, which in turn depends on extracellular Ca2+ influx. Increased PtdSer exposure coincides with increased [Ca2+]i and was observed in a subpopulation ({approx}14%) of the platelets after stimulation with thrombin plus collagen. 2D2-Fab fragments against the thrombin binding site on GPIb{alpha} made clear that this receptor did not signal for platelet procoagulant activity. Inhibition of protease-activated receptor 1 (PAR-1) and PAR-4 by selective intracellular inhibitors and selective desensitization of these receptors revealed that PAR-1, but not PAR-4, activation is a prerequisite for both sustained elevations in [Ca2+]i and procoagulant activity induced by collagen plus thrombin.

Conclusions— The interaction of thrombin with PAR-1 mediates a synergistic effect on collagen-induced procoagulant activity by inducing a sustained elevation in [Ca2+]i in a subpopulation of platelets.

Our study demonstrates that the interaction of thrombin with PAR-1 mediates a synergistic effect on collagen-induced platelet procoagulant activity by inducing a sustained elevation in [Ca2+]i in a subpopulation of platelets.


Key Words: thrombin • collagen • platelets • procoagulant activity • protease-activated receptors




This article has been cited by other articles:


Home page
BloodHome page
S. A. Maroney, S. L. Haberichter, P. Friese, M. L. Collins, J. P. Ferrel, G. L. Dale, and A. E. Mast
Active tissue factor pathway inhibitor is expressed on the surface of coated platelets
Blood, March 1, 2007; 109(5): 1931 - 1937.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. C. Hughan, C. E. Hughes, O. J.T. McCarty, E. Schweighoffer, I. Soultanova, J. Ware, V. L.J. Tybulewicz, and S. P. Watson
GPVI Potentiation of Platelet Activation by Thrombin and Adhesion Molecules Independent of Src Kinases and Syk
Arterioscler. Thromb. Vasc. Biol., February 1, 2007; 27(2): 422 - 429.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. L. Wolfs, S. J. Wielders, P. Comfurius, T. Lindhout, J. C. Giddings, R. F. Zwaal, and E. M. Bevers
Reversible inhibition of the platelet procoagulant response through manipulation of the Gardos channel
Blood, October 1, 2006; 108(7): 2223 - 2228.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. J. Leger, L. Covic, and A. Kuliopulos
Protease-Activated Receptors in Cardiovascular Diseases
Circulation, September 5, 2006; 114(10): 1070 - 1077.
[Abstract] [Full Text] [PDF]